We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 1,711

Can Swiss-style claims go off-piste in Australia?
  • FPA Patent Attorneys
  • Australia
  • March 6 2017

Can Swiss-style claims go off-piste in Australia? Is it possible under Australian law for Swiss-style claims to cover the use of compounds in methods


Has “Raising the Bar” actually raised the bar on inventive step?
  • Shelston IP Pty Ltd
  • Australia
  • March 2 2017

Nearly four years ago, on 15 April 2013, Australian patent law entered a brave new world. Gone were the days of so-called "soft" patentability


Poisonous Priority: Is it a problem?
  • Shelston IP Pty Ltd
  • Australia, European Union, New Zealand
  • March 1 2017

The European Patent Office (EPO) recently issued its reasoned decision clarifying the EPO's stance regarding partial priority (sometimes called


IP Law Changes Imminent and Necessary for Innovation
  • McInnes Wilson Lawyers
  • Australia
  • February 28 2017

In a recent article Patent Attorney Dr Mark Sommerfield comments on the 6 January Productivity Commission report on the country’s IP system. Patents


LYRICA: Timing of a PBS Application
  • Wrays
  • Australia
  • February 27 2017

The recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 3) 2017 FCA 94 (Apotex No 3) highlights the importance of the timing of an


Big data, big risk - investing in a “largely theoretical” industry
  • King & Wood Mallesons
  • Australia
  • February 24 2017

Between 31 May 2012 and 26 March 2013, an Australian husband and wife (Mr and Ms Vinson), through their self-managed superannuation funds, invested


The importance of Swiss-style claims in Australia
  • Shelston IP Pty Ltd
  • Australia
  • February 24 2017

As reported previously, the Federal Court (Nicholas J) confirmed in Apotex Pty Ltd v Warner-Lambert Company LLC (No 3) 2017 FCA 94 that offers made


Swiss-style patent claims can be very valuable in Australia
  • FPA Patent Attorneys
  • Australia
  • February 23 2017

The scope for enforcement of Swiss-style claims may be broader in Australia than for method of medical treatment claims. Second medical use


When can a patent be infringed? The Federal Court provides some answers for the pharmaceutical industry
  • Griffith Hack
  • Australia
  • February 21 2017

Does an offer to supply a product before a patent expires infringe that patent? Yes. Does applying to list a drug on the Pharmaceutical Benefits


Health Alert (Australia) 20 February 2017
  • DLA Piper LLP
  • Australia
  • February 21 2017

In October 2016, Apotex brought proceedings against the Pfizer Group challenging the validity of a patent